User contributions for Lazy
From Glioblastoma Treatments
Jump to navigationJump to search
31 March 2024
- 11:0011:00, 31 March 2024 diff hist +291 Category:Other Chemotherapy and Cancer Drugs No edit summary current
- 10:5910:59, 31 March 2024 diff hist 0 Category:Antibody-Drug Conjugates and other protein-drug conjugates →List of Treatments current
- 10:5710:57, 31 March 2024 diff hist +146 Category:Antibody-Drug Conjugates and other protein-drug conjugates No edit summary
- 10:5510:55, 31 March 2024 diff hist +14 Category:Antibody-Drug Conjugates and other protein-drug conjugates No edit summary
- 10:5410:54, 31 March 2024 diff hist +14 Category:Nutraceuticals No edit summary current
- 10:5410:54, 31 March 2024 diff hist +14 Category:Hormones No edit summary current
- 10:5410:54, 31 March 2024 diff hist +14 Category:Repurposed Drugs No edit summary current
- 10:5110:51, 31 March 2024 diff hist +16 Template:TreatmentInfo No edit summary
- 10:4810:48, 31 March 2024 diff hist +15 Main Page No edit summary
- 07:2407:24, 31 March 2024 diff hist −31 Main Page No edit summary
- 07:2307:23, 31 March 2024 diff hist +920 Main Page No edit summary
30 March 2024
- 22:0122:01, 30 March 2024 diff hist −1 Main Page No edit summary
- 21:4921:49, 30 March 2024 diff hist +1,903 N CPT-11 (Irinotecan) Created page with "{{TreatmentInfo |drug_name=CPT-11 (Irinotecan) |FDA_approval=Approved for the treatment of colon cancer; under investigation for recurrent glioma |used_for=Recurrent Glioblastoma Multiforme (GBM) and other malignant gliomas |clinical_trial_phase=Phase I/II trials in combination with other therapies |common_side_effects=Hematologic, gastrointestinal, and hepatic toxicities noted; acceptable safety profile in combination regimens |OS_without=Not directly specified; histori..." current
- 21:4721:47, 30 March 2024 diff hist +1,948 N Carboplatin Created page with "{{TreatmentInfo |drug_name=Carboplatin |FDA_approval=Yes, approved for various cancers including ovarian and lung cancer; used off-label for GBM |used_for=Recurrent Glioblastoma Multiforme (GBM) and high-grade glioma |clinical_trial_phase=Exploratory and Phase 1/2 trials for recurrent glioma in combination with other agents |common_side_effects=Less toxicity compared to cisplatin, but may include myelosuppression, nausea, and potential for liver enzyme elevation |OS_with..." current
- 21:4521:45, 30 March 2024 diff hist +2,165 N Fotemustine Created page with "{{TreatmentInfo |drug_name=Fotemustine |FDA_approval=Available in Europe, not FDA-approved in the United States for GBM |used_for=Recurrent Glioblastoma Multiforme (GBM) after the standard Stupp protocol treatment |clinical_trial_phase=Varied, with multiple studies evaluating efficacy and optimal scheduling |common_side_effects=Not specified, typical of nitrosoureas may include myelosuppression, nausea, and liver enzyme elevation |OS_without=Not specified |OS_with=Not sp..." current
- 21:4221:42, 30 March 2024 diff hist +2,138 N BCNU (Carmustine) Created page with "{{TreatmentInfo |drug_name=BCNU (Carmustine) |FDA_approval=Yes, approved for treatment of brain tumors, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphomas |used_for=Recurrent Glioblastoma Multiforme (GBM) after radiation treatment |clinical_trial_phase=Various, given its long history of use |common_side_effects=Hepatic and pulmonary toxicity, myelosuppression |OS_without=Not specified in the provided context |OS_with=Not specified in the provided context |P..." current
- 21:3921:39, 30 March 2024 diff hist +1,923 N VAL-083 (Dianhydrogalactitol) Created page with "{{TreatmentInfo |drug_name=VAL-083 (Dianhydrogalactitol) |FDA_approval=Approved in China for CML and lung cancer; not yet approved outside of China for GBM |used_for=Recurrent Glioblastoma Multiforme (GBM) with unmethylated MGMT promoter |clinical_trial_phase=Phase 2 (ongoing evaluation in GBM AGILE for various GBM subtypes) |common_side_effects=Myelosuppression, including neutropenia and lymphopenia; some instances of serious adverse events possibly related to VAL-083 |..." current
- 11:0811:08, 30 March 2024 diff hist 0 BCNU (Carmustine) and Gliadel (Carmustine Wafers) No edit summary
- 10:2010:20, 30 March 2024 diff hist +24 N Template:CustomTextDisplay Created page with "{{{Has original text|}}}" current
- 10:2010:20, 30 March 2024 diff hist +36 Main Page →Optune (formerly NovoTTF-100A) by Novocure
- 10:1610:16, 30 March 2024 diff hist +23 Main Page →Optune (formerly NovoTTF-100A) by Novocure
- 10:1510:15, 30 March 2024 diff hist +5 Main Page →Available Treatments
- 10:1310:13, 30 March 2024 diff hist +23 Template:TreatmentInfo No edit summary
- 10:1110:11, 30 March 2024 diff hist +80 Main Page →Optune (formerly NovoTTF-100A) by Novocure
- 10:0910:09, 30 March 2024 diff hist +1 Template:TreatmentInfo No edit summary
- 10:0810:08, 30 March 2024 diff hist +105 Template:TreatmentInfo No edit summary
- 10:0710:07, 30 March 2024 diff hist +154 Next-Generation CAR T-Cell Therapy for GBM No edit summary current
- 10:0410:04, 30 March 2024 diff hist +2,325 N Next-Generation CAR T-Cell Therapy for GBM Created page with "{{TreatmentInfo |drug_name=Next-Generation CAR T-Cell Therapy for GBM |FDA_approval=In trial phase for GBM; FDA-approved for other cancers |used_for=Recurrent Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase 1 (INCIPIENT trial among others) |common_side_effects=Fevers, altered mental status shortly after infusion, significant but manageable neurotoxicity |OS_without=Median survival for recurrent GBM typically less than one year |OS_with=Not fully established; dr..." Tag: Visual edit: Switched
- 09:3509:35, 30 March 2024 diff hist +51 Main Page →Vaccines Tag: Visual edit
- 09:3409:34, 30 March 2024 diff hist +106 Main Page →Promising new Treatments Tag: Visual edit
- 09:3009:30, 30 March 2024 diff hist −1 Main Page →Other Chemotherapy and Cancer Drugs Tag: Visual edit
- 00:4000:40, 30 March 2024 diff hist +1,820 EGFR inhibitors: Iressa, Tarceva, and Erbitux (gefitinib, erlotinib, and No edit summary current
- 00:3500:35, 30 March 2024 diff hist 0 Main Page →Other Chemotherapy and Cancer Drugs
- 00:3400:34, 30 March 2024 diff hist +48 Main Page →Other Chemotherapy and Cancer Drugs
- 00:3300:33, 30 March 2024 diff hist +16,888 Main Page →Other Chemotherapy and Cancer Drugs
- 00:2900:29, 30 March 2024 diff hist −64 Radiation via Monoclonal Antibodies No edit summary current
- 00:2800:28, 30 March 2024 diff hist +446 Main Page →Radiation via Monoclonal Antibodies
29 March 2024
- 22:5722:57, 29 March 2024 diff hist +636 Main Page →Proton radiation therapy
- 22:5622:56, 29 March 2024 diff hist +503 Main Page No edit summary
- 22:5222:52, 29 March 2024 diff hist +79 Gamma Knife Radiosurgery No edit summary current
- 22:5122:51, 29 March 2024 diff hist +1,721 N Gamma Knife Radiosurgery Created page with "{{TreatmentInfo |drug_name=Gamma Knife Radiosurgery (GKRS) for GBM |FDA_approval=Yes |used_for=Newly diagnosed Glioblastoma Multiforme (GBM) |clinical_trial_phase=N/A (Established treatment modality) |common_side_effects=Lower compared to traditional GBM treatments, with no significant radiation-induced toxicities reported in recent studies. |OS_without=14-16 months with standard treatment. |OS_with=Comparable to standard treatment, specifics depend on individual patient..."
- 22:3722:37, 29 March 2024 diff hist −464 Radiation via Monoclonal Antibodies No edit summary
- 22:3522:35, 29 March 2024 diff hist +2,677 N Radiation via Monoclonal Antibodies Created page with "<includeonly> {| class="wikitable" |- ! Property !! Information |- | Drug Name || Radiation via Monoclonal Antibodies |- | FDA Approval || Under research, not yet FDA-approved for general use |- | Used for || Glioblastoma (GBM) and potentially other high-grade glioma tumors |- | Clinical Trial Phase || Various phases, with some treatments in early clinical trials |- | Common Side Effects || Side effects vary depending on the specific monoclonal antibody and radioactive c..."
- 18:4118:41, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 18:4018:40, 29 March 2024 diff hist −130 Main Page →Proton radiation therapy
- 18:2818:28, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 18:2418:24, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 18:2318:23, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 18:2218:22, 29 March 2024 diff hist 0 Main Page →Proton radiation therapy
- 18:2118:21, 29 March 2024 diff hist −34 Main Page →Proton radiation therapy